Post-Transplant Lymphoproliferative Disorders
Post-transplant lymphoproliferative disorders are a group of conditions that straddle the borders between infection and malignancy. They were very rare prior to the mid-1980s but now can be expected to develop in 1-10% of transplant recipients. While some cases are reversible with reduction in immun...
Corporate Author: | |
---|---|
Other Authors: | , , |
Format: | Electronic eBook |
Language: | English |
Published: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
2010.
|
Subjects: | |
Online Access: | Full Text via HEAL-Link |
Table of Contents:
- Historical Perspective on the Early Studies of Posttransplant Lymphoproliferative Disorders (PTLD)
- Epidemiology of PTLD
- The Biology of Epstein—Barr Virus and Posttransplant Lymphoproliferative Disease
- Epstein—Barr Viral Load Testing: Role in the Prevention, Diagnosis and Management of Posttransplant Lymphoproliferative Disorders
- Clinical Features and Diagnostic Evaluation of Posttransplant Lymphoproliferative Disorder
- Pathology
- Prognostic Factors for PTLD
- Treatment of PTLD
- Prevention of Epstein—Barr Virus Infection and Posttransplant Lymphoproliferative Disease Following Transplantation
- Organ Specific Issues of PTLD — Kidney
- Posttransplantation Lymphoproliferative Disorder (PTLD) in Liver and Small Bowel Transplant Recipients
- Heart and Lung Transplantation
- Posttransplant Lymphoproliferative Disease (PTLD) in Hematopoietic Stem Cell Transplantation (HSCT)
- Research Priorities and Future Directions.